全文获取类型
收费全文 | 16450篇 |
免费 | 1117篇 |
国内免费 | 31篇 |
学科分类
医药卫生 | 17598篇 |
出版年
2023年 | 84篇 |
2022年 | 130篇 |
2021年 | 309篇 |
2020年 | 204篇 |
2019年 | 306篇 |
2018年 | 321篇 |
2017年 | 239篇 |
2016年 | 312篇 |
2015年 | 382篇 |
2014年 | 481篇 |
2013年 | 794篇 |
2012年 | 1162篇 |
2011年 | 1224篇 |
2010年 | 574篇 |
2009年 | 556篇 |
2008年 | 1050篇 |
2007年 | 1179篇 |
2006年 | 1135篇 |
2005年 | 1136篇 |
2004年 | 1134篇 |
2003年 | 1076篇 |
2002年 | 1019篇 |
2001年 | 131篇 |
2000年 | 103篇 |
1999年 | 143篇 |
1998年 | 205篇 |
1997年 | 190篇 |
1996年 | 181篇 |
1995年 | 166篇 |
1994年 | 133篇 |
1993年 | 117篇 |
1992年 | 78篇 |
1991年 | 72篇 |
1990年 | 81篇 |
1989年 | 72篇 |
1988年 | 75篇 |
1987年 | 51篇 |
1986年 | 62篇 |
1985年 | 61篇 |
1984年 | 71篇 |
1983年 | 73篇 |
1982年 | 73篇 |
1981年 | 86篇 |
1980年 | 77篇 |
1979年 | 64篇 |
1978年 | 50篇 |
1977年 | 52篇 |
1976年 | 49篇 |
1975年 | 27篇 |
1974年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Intracellular pH changes affect excitation-contraction coupling in skeletal, and cardiac muscles. However the proton implication
in modulating the sarcoplasmic reticulum Ca2+ release channel activity has never been visualized at single channel level. A large conducting Ca2+ release pathway has previously been characterized after incorporation of skeletal and cardiac sarcoplasmic reticulum vesicles
into planar lipid bilayers. This channel has been activated by micromolar and millimolar concentrations of Ca2+ and ATP, respectively. The pH was independently varied on each side of the channels. Acidification of the cis-chamber (7.4
to 6.6) induced a modification of the gating behaviour, resulting in a decrease of the open probability. This effect was completely
reversible. On the other hand, acidification of the trans-chamber (7.4 to 6.8) induced a reduction of the unitary conductance
of the sarcoplasmic reticulum Ca2+ release channel. 相似文献
102.
Throckmorton AL Allaire PE Gutgesell HP Matherne GP Olsen DB Wood HG Allaire JH Patel SM 《ASAIO journal (American Society for Artificial Internal Organs : 1992)》2002,48(3):216-221
Ventricular assist devices (VADs) are a valid option for long term circulatory support in pediatric patients with postoperative myocardial failure or debilitating heart defects. Most clinical experience to date has involved the short-term support of patients weighing 6 kg and larger. For cases of VAD implementation in pediatric patients, the assist device showed tremendous promise in reversing cardiac failure and providing adequate support as a bridge to cardiac transplantation. The Medos-HIA system, Berlin Heart, Medtronic Bio-Medicus Pump, Abiomed BVS 5000, Toyobo-Zeon pumps, and Hemopumps have proven successful for short-term circulatory support for the pediatric population. The Jarvik 2000 and Pierce-Donachy pediatric system further demonstrate the potential to be used for pediatric circulatory support. The clinical and experimental success of these support systems provide encouragement to believe that long-term support is possible. 相似文献
103.
A phase II trial of temozolomide and IFN-alpha in patients with advanced renal cell carcinoma. 总被引:1,自引:0,他引:1
Usha Sunkara Janet R Walczak Lori Summerson Theresa Rogers Mario Eisenberger Samuel Denmeade Roberto Pili Carol Ann Huff Victoria Sinibaldi Michael A Carducci 《Journal of interferon & cytokine research》2004,24(1):37-41
The combination of temozolomide (TEM) and interferon-alpha (IFN-alpha) previously demonstrated a 30% response rate in metastatic melanoma. A single institution, phase II trial evaluating the efficacy of TEM/IFN in patients with advanced renal cell carcinoma (RCC) was conducted. Safety and tumor response were the main outcomes. Eligible patients received 200 mg/m(2)/day TEM orally on days 1-5 every 28 days, with IFN 2.5 million U/m(2)/day subcutaneously (s.c.) three alternate days/week for days 1-15 first cycle, then 5 million U/m(2)/day s.c. 3 alternate days/week throughout each 28-day cycle. Efficacy was evaluated every 8 weeks, and dose-limiting toxicities (DLTs) were treated with dose reductions of the culprit drug. Sixteen patients (ages 37-67) were initially enrolled. Of the 14 evaluable patients, there was one minor response. Best response was stable disease, with 7 patients remaining on study for > or =6 months. Five were alive for more than 2 years, and 2 remain alive at 45 and 50 months after enrollment. DLTs included TEM-induced myelosuppression and IFN-induced fever/chills. Other toxicities were mild to moderate (grades 1-3). The combination of TEM/IFN proved quite tolerable. This regimen appears inactive in terms of response in this population with poor prognosis, but the patients with stable disease > or =6 months remain of interest. 相似文献
104.
PURPOSE OF REVIEW: Parallel increases in many inflammatory diseases over the last 40 years suggest that common environmental changes are promoting inflammatory immune responses and/or inhibiting the processes that normally keep these in check. One key change during this period has been declining intakes of anti-inflammatory dietary factors, including omega-3 polyunsaturated fatty acids (n-3 PUFA). As allergic diseases often first manifest in early infancy, prevention strategies need to be targeted early, even in utero. This review will examine recent evidence for the use of fish oil during this early period as a primary prevention strategy for allergic disease. RECENT FINDINGS: N-3 PUFA have well documented anti-inflammatory effects in vitro and have also been demonstrated to have health benefits in a range of chronic inflammatory diseases, including cardiovascular disease, rheumatoid arthritis and diabetes, supporting their role in modulating inflammation in vivo. Although the effects of fish oil supplementation in established allergic disease are less convincing, there is accumulating evidence that dietary n-3 PUFA may have greater effects before allergic responses are established. SUMMARY: Supplementation of the maternal diet in pregnancy with n-3 PUFA may provide a non-invasive intervention with significant potential to prevent the development of allergic and possibly other immune-mediated diseases. 相似文献
105.
106.
Shimon Harrus Trevor Waner Itzhak Aizenberg Janet E. Foley Amy M. Poland Hylton Bark 《Journal of clinical microbiology》1998,36(1):73-76
In order to determine whether dogs in the subclinical phase of canine monocytic ehrlichiosis (CME) are carriers of Ehrlichia canis and to determine the significance of persistent indirect immunofluorescent anti-E. canis antibody titers during this phase, PCR was performed with blood, bone marrow, and splenic aspirates collected 34 months postinoculation from six clinically healthy beagle dogs experimentally infected with E. canis. At least one of the three samples (spleen, bone marrow, and blood) from four of the six dogs was PCR positive. The spleens of all four of these dogs were PCR positive, and the bone marrow and blood of two of the four dogs were PCR positive. Indirect immunofluorescent-antibody titers increased progressively during the first 5 months postinfection, remained high for an additional period of more than 11 months, and declined thereafter, suggesting that the dogs were recovering from the disease. Five of the dogs remained seropositive 34 months postinfection. The data obtained in this study demonstrate for the first time that clinically healthy dogs in the subclinical phase of CME are carriers of the rickettsia. It was shown that dogs can harbor E. canis for years without developing the chronic clinical disease and that dogs can eliminate the parasite and recover from CME without medical treatment. Our findings suggest that the spleen is the organ most likely to harbor E. canis parasites during the subclinical phase and the last organ to accommodate the parasite before elimination. It was concluded that PCR of DNA extracted from splenic aspirates is a reliable method for determining the carrier state of CME. 相似文献
107.
David Baker Debra Butler Bernard J. Scallon Janet K. O'Neill John L. Turk Marc Feldmann 《European journal of immunology》1994,24(9):2040-2048
Tumor necrosis factor (TNF) activity was inhibited during the development of actively-induced, chronic relapsing experimental allergic encephalomyelitis (CREAE) in Biozzi AB/H mice, using a mouse TNF-specific (TN3.19.12) antibody and bivalent human p55 and p75 TNF receptor-immunoglobulin (TNFR-Ig) fusion proteins. The development of disease could be inhibited when repeated doses of antibody were administered prior to the anticipated onset. It has now also been shown that a therapeutic effect is evident even when antibody is administered after the onset of clinical signs, further indicating an important role for TNF in pathogenic effector mechanisms in CREAE. Although biologically-active TNF was not detected in the circulation, TNF-α was detected in lesions within the central nervous system (CNS). This suggested that the CNS may be the main site for TNF-specific immunomodulation and was supported by the observation that intracranial injection was significantly more potent than that administered systemically, for both antibody and TNFR-Ig fusion proteins. The fusion proteins were as effective as antibody at doses 10—100-fold lower than that used for antibody, reflecting their higher neutralizing capacity in vitro. Although treatment was not curative and relapse inevitably occurred in this model if treatment was not sustained, the data indicate that anti-TNF immunotherapy, especially within the CNS, can inhibit CREAE and may, therefore, be useful in the control of human neuroimmunological diseases. 相似文献
108.
The hemopoietic specific, Src homology 2-containing inositol 5' phosphatase (SHIP) hydrolyzes the phosphatidylinositol (PI)-3-kinase generated second messenger, PI-3,4,5-trisphosphate (PIP(3)), to PI-3,4-bisphosphate (PI-3,4-P(2)) in normal bone marrow derived mast cells (BMMCs). As a consequence, SHIP negatively regulates IgE+antigen (Ag)-induced degranulation as well as leukotriene and inflammatory cytokine production. Interestingly, in the absence of SHIP, BMMCs degranulate extensively with IgE alone, i.e. without Ag, suggesting that IgE alone is capable of stimulating signaling in normal BMMCs and that SHIP prevents this signaling from progressing to degranulation. To test this, we compared signaling events triggered by monomeric IgE versus IgE+Ag in normal BMMCs and found that multiple pathways are triggered by monomeric IgE alone and, while they are in general weaker than those stimulated by IgE+Ag, they are more prolonged. Moreover, while SHIP prevents this IgE-induced signalling from progressing to degranulation or leukotriene production it allows sufficient production of autocrine acting cytokines, in part by activation of NFkappaB, to enhance BMMC survival. Interestingly, the activation of NFkappaB and the level of cytokines produced are far higher with IgE than with IgE+Ag. Moreover, IgE alone maintains Bcl-X(L) levels and enhances the adhesion of BMMCs to fibronectin and this likely enhances their survival still further. 相似文献
109.
Danila Valmori Jackeline F. Romero Ying Men Janet L. Maryanski Pedro Romero Giampietro Corradin 《European journal of immunology》1994,24(6):1458-1462
We have previously demonstrated that it is possible to induce a consistent and strong cytolytic T lymphocyte (CTL) response to synthetic peptides, corresponding to poorly immunogenic malaria CTL epitopes, by co-injecting them with peptides representing defined T helper (Th) epitopes in incomplete Freund's adjuvant (IFA). In this study we have tested different immunization protocols to improve further the elicitation of the CTL response. We show that the CTL response to a mixture of Th + CTL peptides administered in IFA was further enhanced by a previous injection of the Th epitope peptide in IFA. Moreover, we found that the response could be significantly augmented by a pre-injection of IFA alone. This enhancement was observed only if the Th epitope was also present in the second injection. The number of lymph node cells recovered was 2–3-fold higher in mice pre-injected with IFA, but the increase in specific CTL activity, expressed as lytic units per animal, by pre-injection of IFA was at least 10–20-fold. Thus, pre-injection of IFA clearly increases the magnitude of a subsequent CTL response. 相似文献
110.
Silviu-Alin Bacanu Cynthia M Bulik Kelly L Klump Manfred M Fichter Katherine A Halmi Pamela Keel Allan S Kaplan James E Mitchell Alessandro Rotondo Michael Strober Janet Treasure D Blake Woodside Vibhor A Sonpar Weiting Xie Andrew W Bergen Wade H Berrettini Walter H Kaye Bernie Devlin 《American journal of medical genetics. Part B, Neuropsychiatric genetics》2005,(1):61-68
To increase the likelihood of finding genetic variation conferring liability to eating disorders, we measured over 100 attributes thought to be related to liability to eating disorders on affected individuals from multiplex families and two cohorts: one recruited through a proband with anorexia nervosa (AN; AN cohort); the other recruited through a proband with bulimia nervosa (BN; BN cohort). By a multilayer decision process based on expert evaluation and statistical analysis, six traits were selected for linkage analysis (1): obsessionality (OBS), age at menarche (MENAR), and anxiety (ANX) for quantitative trait locus (QTL) linkage analysis; and lifetime minimum body mass index (BMI), concern over mistakes (CM), and food-related obsessions (OBF) for covariate-based linkage analysis. The BN cohort produced the largest linkage signals: for QTL linkage analysis, four suggestive signals: (for MENAR, at 10p13; for ANX, at 1q31.1, 4q35.2, and 8q13.1); for covariate-based linkage analyses, both significant and suggestive linkages (for BMI, one significant [4q21.1] and three suggestive [3p23, 10p13, 5p15.3]; for CM, two significant [16p13.3, 14q21.1] and three suggestive [4p15.33, 8q11.23, 10p11.21]; and for OBF, one significant [14q21.1] and five suggestive [4p16.1, 10p13.1, 8q11.23, 16p13.3, 18p11.31]). Results from the AN cohort were far less compelling: for QTL linkage analysis, two suggestive signals (for OBS at 6q21 and for ANX at 9p21.3); for covariate-based linkage analysis, five suggestive signals (for BMI at 4q13.1, for CM at 11p11.2 and 17q25.1, and for OBF at 17q25.1 and 15q26.2). Overlap between the two cohorts was minimal for substantial linkage signals. 相似文献